In Vivo CD4


Journal

Annual review of immunology
ISSN: 1545-3278
Titre abrégé: Annu Rev Immunol
Pays: United States
ID NLM: 8309206

Informations de publication

Date de publication:
26 04 2020
Historique:
entrez: 29 4 2020
pubmed: 29 4 2020
medline: 12 8 2021
Statut: ppublish

Résumé

The discovery of CD4

Identifiants

pubmed: 32340571
doi: 10.1146/annurev-immunol-103019-085803
doi:

Substances chimiques

Cytokines 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

705-725

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI108626
Pays : United States

Auteurs

Mikel Ruterbusch (M)

Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98109, USA; email: mikelr@uw.edu, mpepper@uw.edu.

Kurt B Pruner (KB)

Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98109, USA; email: mikelr@uw.edu, mpepper@uw.edu.

Laila Shehata (L)

Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98109, USA; email: mikelr@uw.edu, mpepper@uw.edu.

Marion Pepper (M)

Department of Immunology, University of Washington School of Medicine, Seattle, Washington 98109, USA; email: mikelr@uw.edu, mpepper@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH